100 deals in 1,000 days Update

100 transactions in 1,000 days

100 transactions in 1,000 days for +100% annual returns

We have recently completed our 100th transaction.  OnMarket launched its B2C platform in October 2015, approximately 1,000 days ago.  OnMarket, which is now approaching 50,000 members, provides retail investors with access to over one third of all IPOs on the ASX.

Read the blog here

SHARE


.

Discover investment opportunities here.

 

NASDAQ IPO Offer Closed

GenEmbryomics Ltd NASDAQ: XGEN

Providing next generation genetic testing for the global IVF industry

 

Nasdaq IPO only open to Professional, Sophisticated and Experienced investors

 

GenEmbryomics Ltd (NASDAQ: XGEN) is an Australian genomics-based company providing the ability to screen IVF embryos for over 3,200 severe and fatal genetic diseases. Their flagship test provides genetic testing via whole genome sequencing reducing the risk of having a child with a genetic disorder. Targeting the US$36bn global assisted fertility market, the test is being commercialised in the US with Progenesis Inc., a global fertility services provider.

$1.00Price
Up to US$5.2 millionSize of Offer
21 Mar 25Offer Open
28 Mar 25Pay By
CSF Register for early access

CHEFIN Australia Pty Ltd

Reshaping the ever-growing private dining market

 

CHEFIN brings diners and top private chefs together to create unforgettable dining experiences, backed by a scalable and proven business model. Since its inception, CHEFIN has generated $6M in revenue, built a network of 1,035 C-level chefs, and successfully hosted 3,000 bookings for over 118,580 diners.

CSF Closed Mar 2025

Prohibition Liquor Co. Ltd

The Prohibition Liquor Co. Ltd CSF offer has closed successfully. Prohibition has grown into one of Australia’s most awarded and respected distilleries, earning hundreds of international accolades. They are now embarking on an exciting new chapter—expanding to the historic Seppeltsfield Distillery in the Barossa Valley

Fully Funded

$2.61 million

Raised

1,128

Investors